Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Carcinoma, Ovarian Epithelial 2Testicular Neoplasms 1Small Cell Lung Carcinoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Lethal Congenital Contracture Syndrome 2 1Hodgkin Disease 1Graft vs Host Disease 1Esophageal Squamous Cell Carcinoma 1

Interventions

enzalutamide 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lethal Congenital Contracture Syndrome 2 × In Situ Hybridization, Fluorescence × Breast × Clear all
NCT00740532 2010-09-02

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Istituto Clinico Humanitas

Completed
11 enrolled
Breast

Lethal Congenital Contracture Syndrome 2, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡